Seysara (Sarecycline)

Class: Tetracycline

Spectrum of activity:	Gram-positive
Institute where first reported:	Hospital ABC Campus Santa Fe, Mexico
Year first mentioned:	2020
Highest developmental phase:	Preclinical

Chemical structure(s):
Canonical SMILES:	CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)CN(C)OC
Isomeric SMILES:	CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)CN(C)OC
InChI:	InChI=1S/C24H29N3O8/c1-26(2)18-13-8-11-7-12-10(9-27(3)35-4)5-6-14(28)16(12)19(29)15(11)21(31)24(13,34)22(32)17(20(18)30)23(25)33/h5-6,11,13,18,28-29,32,34H,7-9H2,1-4H3,(H2,25,33)/t11-,13-,18-,24-/m0/s1
InChI Key:	AYUMVPHUMFKFPJ-SBAJWEJLSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/54681908

External links:
Guide to Pharmacology:	sarecycline
Main Source:	https://www.tandfonline.com/doi/full/10.1080/14656566.2020.1813279